Antibody Discovery Global Market Report 2026

Antibody discovery is the process of identifying and developing antibodies, which are proteins produced by the immune system to protect the body against harmful agents, such as bacteria and viruses. Antibodies, also called immunoglobulins, are essential to the immune response as they recognize and bind to specific molecules known as antigens.

The main methods used in antibody discovery include phage display, hybridoma, and others. Phage display is a molecular biology technique used to study and select peptides or proteins, often antibodies, that bind with high affinity to a specific target. It is widely used in antibody discovery to generate and identify antibodies with precise binding characteristics. The types of antibodies include humanized antibodies, human antibodies, chimeric antibodies, and murine antibodies, which are utilized by end users in the pharmaceutical and biotechnology sectors, research laboratories, and academic institutions.

Tariffs have influenced the antibody discovery market by increasing the cost of importing laboratory equipment, reagents, and raw materials, thereby affecting R&D timelines and operational budgets. Regions such as North America and Europe, which rely on imports for high-end screening instruments and biotechnology components, are particularly impacted. Segments including high-throughput screening and synthetic antibody development face higher costs, potentially slowing research and production. However, tariffs have also encouraged local manufacturing and supply chain diversification, promoting innovation and resilience in the market.

The antibody discovery market research report is one of a series of new reports from The Business Research Company that provides antibody discovery market statistics, including antibody discovery industry global market size, regional shares, competitors with a antibody discovery market share, detailed antibody discovery market segments, market trends and opportunities, and any further data you may need to thrive in the antibody discovery industry. This antibody discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antibody discovery market size has grown strongly in recent years. It will grow from $9.78 billion in 2025 to $10.75 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increased r&d investments in antibody discovery, rising prevalence of infectious and chronic diseases, advances in hybridoma technology, government funding for biotechnology research, collaboration between academic institutions and pharma,.

The antibody discovery market size is expected to see rapid growth in the next few years. It will grow to $15.79 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growth in personalized medicine demand, adoption of ai and ml in drug discovery, expansion of biologics market, integration of high-throughput screening platforms, rising focus on immunotherapy and targeted therapies. Major trends in the forecast period include high-throughput screening techniques, monoclonal antibody advancements, personalized antibody therapeutics, multi-specific antibody development, synthetic antibody engineering.

The increasing demand for precision therapeutics is expected to drive the growth of the antibody discovery market in the coming years. Precision therapeutics, also called personalized therapeutics, involves tailoring medical treatment plans and interventions to the unique characteristics of individual patients. Antibody discovery supports precision therapeutics by enabling the development of targeted therapies, such as monoclonal antibodies, that interact specifically and precisely with disease-related molecules or cells, resulting in more effective and personalized treatment. For instance, in March 2024, IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare sectors, reported that global spending on cell and gene therapies reached $5.9 billion in 2023, representing a 38% increase from 2022. Therefore, the rising need for precision therapeutics is fueling growth in the antibody discovery market.

Major companies in the antibody discovery market are developing innovative technologies, such as AI-based computational antibody drug discovery platforms, to enhance the efficiency and accuracy of antibody development. An AI-based computational antibody drug discovery platform leverages artificial intelligence and computational techniques to accelerate the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company specializing in recombinant proteins from a plant-based system, launched an AI-driven antibody discovery platform. This advanced platform integrates artificial intelligence, big data, machine learning, and phage display techniques to quickly predict high-specificity and high-affinity antibody-antigen interactions. Functioning similarly to natural language processing, the system generates diverse antibody variants, enabling SwiftPharma to efficiently create extensive antibody libraries. This technology significantly accelerates the discovery of potential antibody therapies.

In July 2024, Pentixapharm, a Germany-based radiopharmaceutical biotechnology company, acquired Glycotope's target discovery unit for an undisclosed amount. The acquisition supports Pentixapharm's strategy to expand its oncology pipeline by converting preclinical antibodies targeting multiple cancer antigens into radiopharmaceuticals. In addition to the preclinical assets, Pentixapharm gained Glycotope's laboratories, cell banks, tumor target database, and equipment, further strengthening its intellectual property portfolio beyond the CXCR4 receptor. Glycotope is a Germany-based biotechnology company focused on developing glyco-optimized antibodies for cancer immunotherapy.

Major companies operating in the antibody discovery market are Charles River Laboratories, WuXi Biologics, Genmab A/S, Evotec, ChemPartner, Aragen Life Science Pvt. Ltd., GenScript Technology Corporation, Biocytogen, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A., Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio Technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

North America was the largest region in the antibody discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibody discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibody discovery market includes revenues earned by entities by providing services such as antigen identification, immunization, antibody generation, screening, and characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The antibody discovery market also includes sales of antibody libraries, phage display kits, antigen proteins, and antibody screening platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibody Discovery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses antibody discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibody discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antibody discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Methods: Phage Display; Hybridoma; Other Methods
• 2) By Antibody Type: Humanized Antibody; Human Antibody; Chimeric Antibody; Murine Antibody
• 3) By End Users: Pharmaceutical And Biotechnology Industry; Research Laboratory; Academic Laboratory
• Subsegments:
• 1) By Phage Display: Selection And Screening Techniques; Optimization Methods
• 2) By Hybridoma: Monoclonal Antibody Production; Screening And Selection Processes
• 3) By Other Methods: Transgenic Mouse Technology; B-Cell Engineering; Single-Cell Sorting Techniques
• Companies Mentioned: Charles River Laboratories; WuXi Biologics; Genmab A/S; Evotec; ChemPartner; Aragen Life Science Pvt. Ltd.; GenScript Technology Corporation; Biocytogen; Twist Bioscience; BioDuro-Sundia; Fairjourney Biologics S.A.; Harbour BioMed; Rockland Immunochemicals; Creative Biolabs; Synbio Technologies; ImmunoPrecise; Ablexis; Myrio Therapeutics; Antibody Solutions; MabSilico
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.